Skip to main content

Table 3 The effect of risk factors and medications on survival and secondary endpoints based on Kaplan–Meier analysis

From: The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial

 

Death

Total endpoints

Chi-square

P

Chi-square

P

Female

0.096

0.756

0.145

0.703

Old age(age ≥ 65 years)

0.044

0.833

0.098

0.755

Obesity(BMI ≥ 25 kg/m2)

1.397

0.237

3.168

0.075

CPAP

0.299

0.585

0.771

0.380

Aspirin

0.115

0.735

0.088

0.766

Clopidogrel

6.425

0.011

1.65

0.199

Statin

2.161

0.142

0.994

0.319

Beta-blocker

0.176

0.675

0.083

0.773

ARB

2.355

0.125

2.341

0.126

ACE inhibitors

5.071

0.024

3.307

0.069

CCB

0.391

0.532

0.686

0.408

Nitrates

6.417

0.011

3.087

0.079

  1. CPAP continues positive airway pressure, BMI body mass index, ARB angiotensin receptor inhibitors, ACE angiotensin converting enzyme, CCB calcium channel blocker
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us